Clinical Trial Update: One Year Glargine Treatment in CFRD Children and Adolescents [Phase 4]

View source ↗

Summary

This document provides a Phase 4 update on a one-year insulin glargine treatment in children and adolescents with cystic fibrosis-related diabetes, noting the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Cystic Fibrosis-related Diabetes

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Federico II University | Conditions: Cystic Fibrosis, Glucose Metabolism Disorders | Phase 4 | Status: COMPLETED